American pharmaceutical company Amarin announced the results of clinical trials of its new drug with the addition of omega-3 polyunsaturated fatty acids. It turned out that the substance which is also found in fish oil and other foods, reduces the risk of death from heart attacks and strokes.
Reports mir24.tv in the study, which was conducted by the company, participated 8179 patients. They took the drug with the addition of fish oil to control cholesterol levels in blood and had an elevated risk of cardiovascular disease, for example, due to diabetes. The experimental group took the drug companies, and the control – placebo, patients followed an average of nearly five years.
The developers hoped that the study will show a 15 percent reduction in the risk of death, non-fatal heart attack or stroke, coronary artery bypass grafting or unstable angina, but the actual reduction was 25%.
The drug is well tolerated by patients, and side effects (besides the already known) was not. Earlier clinical trials of drugs with omega-3 showed a significant reduction in the risk of cardiovascular diseases, therefore, the conclusions of the company’s representatives have yet to be tested. Extended test results, the company plans to introduce 10 November at the American heart Association.
Omega-3 fatty acids are found in oily fish and seafood, Flaxseed and mustard oil and some other vegetable oils.